KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $36.6 billion.

  • Pfizer's Total Current Liabilities fell 1530.86% to $36.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $36.6 billion, marking a year-over-year decrease of 1530.86%. This contributed to the annual value of $43.0 billion for FY2024, which is 1004.1% down from last year.
  • Per Pfizer's latest filing, its Total Current Liabilities stood at $36.6 billion for Q3 2025, which was down 1530.86% from $37.7 billion recorded in Q2 2025.
  • Pfizer's 5-year Total Current Liabilities high stood at $47.8 billion for Q4 2023, and its period low was $5.1 billion during Q4 2021.
  • Over the past 5 years, Pfizer's median Total Current Liabilities value was $37.7 billion (recorded in 2025), while the average stood at $35.6 billion.
  • The largest annual percentage gain for Pfizer's Total Current Liabilities in the last 5 years was 49476.6% (2023), contrasted with its biggest fall of 2692.05% (2023).
  • Pfizer's Total Current Liabilities (Quarter) stood at $42.7 billion in 2021, then decreased by 1.25% to $42.1 billion in 2022, then increased by 13.42% to $47.8 billion in 2023, then dropped by 10.04% to $43.0 billion in 2024, then decreased by 14.88% to $36.6 billion in 2025.
  • Its Total Current Liabilities was $36.6 billion in Q3 2025, compared to $37.7 billion in Q2 2025 and $36.5 billion in Q1 2025.